Browse by Author "Olivares Diez, José Manuel"

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER

2012- Olivares Diez, José Manuel

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

2013- Olivares Diez, José Manuel

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN

2013- Olivares Diez, José Manuel

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder

2014- Olivares Diez, José Manuel

Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program

2019- GALLASTEGUI OTERO, MARIA DEL CARMEN; Fernandez-Vega, H.; Piñeiro Corrales, María Guadalupe; REY GOMEZ SERRANILLOS, ISABEL; Olivares Diez, José Manuel; [et al.]

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability

2011- Olivares Diez, José Manuel

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

2012- Olivares Diez, José Manuel

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia

2011- Olivares Diez, José Manuel; Pinal Fernández, Beatriz; Cinos Galan, Carmen Ines

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice

2013- Olivares Diez, José Manuel

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

2013- Olivares Diez, José Manuel

Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

2020- Spuch, C.; López-García, M.; Rivera-Baltanás, T.; Rodrígues-Amorím, D.; Olivares Diez, José Manuel [et al.]

Editorial: Novel approaches to the neuropharmacology of mood disorders

2019- Caruncho, H. J.; Kalynchuk, L. E.; Loza, M. I.; Olivares Diez, José Manuel

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium

2011- Olivares Diez, José Manuel

Improving emotion recognition in schizophrenia with

2019- Lado-Codesido, M.; Perez, C. M.; Mateos Álvarez, Raimundo; Olivares Diez, José Manuel; García Caballero, Alejandro Alberto [et al.]

Improving treatment adherence in your patients with schizophrenia: The STAY initiative

2013- Olivares Diez, José Manuel

Mania as Debut of Cushing's Syndrome

2020- ALVAREZ MARTINEZ, RICARDO; TOME RODRIGUEZ, ROSA MARIA; Alvarez Ariza, Maria; Spuch Calvar, Carlos; Olivares Diez, José Manuel [et al.]

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

2015- Olivares Diez, José Manuel

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

2013- Olivares Diez, José Manuel

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

2012- Olivares Diez, José Manuel

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia

2012- Olivares Diez, José Manuel

RUNA digital repository

Browse by Author "Olivares Diez, José Manuel"

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER ﻿

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain ﻿

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN ﻿

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder ﻿

Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program ﻿

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability ﻿

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study ﻿

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia ﻿

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice ﻿

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review ﻿

Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report ﻿

Editorial: Novel approaches to the neuropharmacology of mood disorders ﻿

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium ﻿

Improving emotion recognition in schizophrenia with ﻿

Improving treatment adherence in your patients with schizophrenia: The STAY initiative ﻿

Mania as Debut of Cushing's Syndrome ﻿

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice ﻿

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain ﻿

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain ﻿

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia ﻿

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder

Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

Editorial: Novel approaches to the neuropharmacology of mood disorders

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium

Improving emotion recognition in schizophrenia with

Improving treatment adherence in your patients with schizophrenia: The STAY initiative

Mania as Debut of Cushing's Syndrome

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia